David Roberge
Overview
Explore the profile of David Roberge including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
146
Citations
4484
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Ramjeesingh R, Chaudhury P, Tam V, Roberge D, Lim H, Knox J, et al.
Curr Oncol
. 2023 Aug;
30(8):7132-7150.
PMID: 37622998
Biliary tract cancers (BTC) are rare and aggressive tumors with poor prognosis. Radical surgery offers the best chance for cure; however, most patients present with unresectable disease, and among those...
12.
Younes N, Bourdeau I, Olney H, Perrotte P, Prosmanne O, Latour M, et al.
Endocr Oncol
. 2023 Jul;
1(1):K7-K12.
PMID: 37435185
Summary: Needle tract seeding is a potential, albeit rare, complication following transcutaneous biopsies, leading to the seeding of tumor cells along the path of the needle. Biopsies of adrenal masses...
13.
Truong V, Al-Shakfa F, Roberge D, Masucci G, Tran T, Dib R, et al.
Asian Spine J
. 2023 Jul;
17(4):739-749.
PMID: 37408290
Study Design: Retrospective study. Purpose: The purpose of this study was to see how well the Tomita score, revised Tokuhashi score, modified Bauer score, Van der Linden score, classic Skeletal...
14.
Tonneau M, Richard C, Routy B, Campeau M, Vu T, Filion E, et al.
Radiother Oncol
. 2023 May;
185:109697.
PMID: 37169303
Introduction: To assess patterns of recurrence after stereotactic ablative radiotherapy (SABR) in patient ineligible to surgery with early-stage non-small cell lung cancer (ES-NSCLC), report survival and treatment after first recurrence....
15.
Guillemette A, Roberge D, Heymann S, Menard C, Bahary J, Fournier-Gosselin M
Can J Neurol Sci
. 2023 May;
51(2):272-277.
PMID: 37154078
Background: CyberKnife radiosurgery (RS), as an initial first treatment, is recognized as an efficient and safe modality for trigeminal neuralgia (TN). However, knowledge on repeat CyberKnife RS in refractory cases...
16.
Gondi V, Deshmukh S, Brown P, Wefel J, Armstrong T, Tome W, et al.
Int J Radiat Oncol Biol Phys
. 2023 May;
117(3):571-580.
PMID: 37150264
Purpose: Initial report of NRG Oncology CC001, a phase 3 trial of whole-brain radiation therapy plus memantine (WBRT + memantine) with or without hippocampal avoidance (HA), demonstrated neuroprotective effects of...
17.
Wong P, Masucci L, Florescu M, Plourde M, Panet-Raymond V, Pavic M, et al.
Neurooncol Adv
. 2023 Apr;
5(1):vdad018.
PMID: 37025758
Background: Anti-PD-1 has activity in brain metastases (BM). This phase II open labeled non-randomized single arm trial examined the safety and efficacy of combining nivolumab with radiosurgery (SRS) in the...
18.
Petrogiannis-Haliotis T, Pehr K, Roberge D, Rys R, Monczak Y, Popradi G, et al.
Biomedicines
. 2023 Feb;
11(2).
PMID: 36831170
We report the case of a patient who was referred to our institution with a diagnosis of CD4+ small/medium-sized pleomorphic lymphoma. At the time, the patient showed a plethora of...
19.
Huntoon K, Anderson S, Ballman K, Twohy E, Dooley K, Jiang W, et al.
Neuro Oncol
. 2022 Dec;
25(6):1123-1131.
PMID: 36472389
Background: A recent phase III trial (NCT01372774) comparing use of stereotactic radiosurgery [SRS] versus whole-brain radiation therapy [WBRT] after surgical resection of a single brain metastasis revealed that declines in...
20.
Guillemette A, Heymann S, Roberge D, Menard C, Fournier-Gosselin M
Neurosurg Focus
. 2022 Nov;
53(5):E4.
PMID: 36321283
Objective: Gamma Knife radiosurgery is recognized as an efficient intervention for the treatment of refractory trigeminal neuralgia (TN). The CyberKnife, a more recent frameless and nonisocentric radiosurgery alternative, has not...